CClinicalTrials.gg
CompletedNCT07593001Updated May 18, 2026

TIME MANAGEMENT DURING HAEMODIALYSIS ON ANXIETY AND FEAR IN CHILDREN

An interventional study of TRAINING GIVEN ON TIME MANAGEMENT and Control in Haemodialysis Patients, Care and Children, sponsored by Istanbul University - Cerrahpasa. Completed at 1 site in Turkey (Türkiye). Open to participants aged 9 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Nov 2025, registered Apr 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
9 Years to 12 Years
Sex
All
01

Study summary

Aim: This study aims to determine the effect of time management training on anxiety and fear levels in children undergoing haemodialysis treatment. It is anticipated that the structured time management training provided to children will contribute to the treatment process.

Method: This study has a randomised controlled experimental design. The study was conducted at the Gaziantep University Sahinbey Research and Application Hospital Children's Nephrology Diseases Hemodialysis Unit between 1 November 2025 and 1 April 2026. The study sample consisted of children aged 9-12 undergoing hemodialysis treatment at this unit. The sample group was randomly divided into intervention and control groups. The intervention group received training after the pre-test, and the training's effectiveness was evaluated one week and one month later. The control group received routine care. Data were collected using a questionnaire, the State-Trait Anxiety Inventory for Children, and the Medical Procedure Fear Scale.

02

Conditions studied

  • Haemodialysis Patients
  • Care
  • Children

Browse trials for

Keywords

  • Child
  • haemodialysis
  • nurse
  • time management
  • anxiety
  • fear
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 20 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Istanbul University - Cerrahpasa is the lead sponsor of 680 studies on the registry; 208 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children aged 9-12,
  • Children who can speak and understand Turkish,
  • Children without communication problems,
  • Children without learning disabilities,
  • Children approved by their families,
  • Children without physical disabilities.

Exclusion criteria

Exclusion Criteria:

  • Children who refuse to participate in the study,
  • Children who do not speak Turkish,
  • Children with communication problems,
  • Children with learning disabilities,
  • Children with intellectual disabilities.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • No intervention
    Control

    Rutin care

  • Experimental
    Training

    Behavioral: TRAINING GIVEN ON TIME MANAGEMENT · Other: Control

Interventions

  • BehavioralTRAINING GIVEN ON TIME MANAGEMENT

    The intervention group received training after the pre-test, and the training's effectiveness was evaluated one week and one month later.

  • OtherControl

    There is no actual intervention, just rutin care

06

What researchers measure

Primary outcomes

  1. the State Anxiety Inventory (Pre-training)

    After obtaining their consent during the first interview, the State Anxiety Inventory, was administered as pre-tests.

    Time frame: 2 months

  2. the Medical Procedure Fear Scale (Pre-training)

    After obtaining their consent during the first interview the Medical Procedure Fear Scale was administered as pre-tests.

    Time frame: 2 mounts

Secondary outcomes

  1. the State Anxiety Inventory, (Post test)

    When evaluating the results of the first measurement one week after training (Final test 1)) State Anxiety Inventory was assessed.

    Time frame: 4 months

  2. the Medical Procedure Fear Scale (Post test)

    When evaluating the results of the first measurement one week after training (Final test 1)) the Medical Procedure Fear Scale was assessed.

    Time frame: 4 months

  3. the State Anxiety Inventory (Post test)

    When evaluating the results of the second measurement one month after training (Final test 2)) the the State Anxiety Inventory was assessed.

    Time frame: 5 mounts

  4. the Medical Procedure Fear Scale (Post test)

    When evaluating the results of the second measurement one month after training (Final test 2)) the Medical Procedure Fear Scale was assessed.

    Time frame: 5 mounts

07

Study locations

1 site
  • Gaziantep University
    Gaziantep, 27310, Turkey (Türkiye)
08

References and documents

Publications

  • Raina M, Shah R, Hu J, Pember B, Cahill T, Bunchman T, Yap HK, McCulloch M. The global health burden of pediatric chronic kidney disease: An analysis of the Global Burden of Disease database from 1990 to 2021. PLoS One. 2025 May 27;20(5):e0323257. doi: 10.1371/journal.pone.0323257. eCollection 2025. PubMed 40424235 ↗
  • Park, M. J. (2023). Anemia in children with chronic kidney disease: Current insights. Children's Kidney Journal, 7(3), 201-210.
  • Panzarino V, Lesser J, Cassani FA. Pediatric Chronic Kidney Disease. Adv Pediatr. 2022 Aug;69(1):123-132. doi: 10.1016/j.yapd.2022.03.008. PubMed 35985704 ↗
  • Hosseini T, Hooshmandja M, Noaparast M, Mojtahedzadeh R, Mohammadi A. Virtual reality exposure therapy to decrease anxiety before surgical invasive procedures in hemodialysis patients: an interventional study. BMC Nephrol. 2024 Jan 24;25(1):30. doi: 10.1186/s12882-024-03461-w. PubMed 38267868 ↗
  • Francis, A., et al. (2024). Key pediatric considerations from the KDIGO 2024 CKD guidelines. JAMA Pediatrics, 178(5), 433-440.
  • Cirillo L, De Chiara L, Innocenti S, Errichiello C, Romagnani P, Becherucci F. Chronic kidney disease in children: an update. Clin Kidney J. 2023 Apr 24;16(10):1600-1611. doi: 10.1093/ckj/sfad097. eCollection 2023 Oct. PubMed 37779846 ↗
  • Akinkugbe, O., et al. (2024). Systematic review of CKD progression mechanisms in pediatric patients. Pediatric Nephrology, 39(4), 789-802.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07593001
Lead sponsor
Istanbul University - Cerrahpasa
Responsible party
SERAP ÖZDEMİR (Assistant Professor, Istanbul University - Cerrahpasa) — Principal investigator
First posted
May 18, 2026
Start date
Nov 1, 2025
Primary completion
Apr 1, 2026
Completion
Apr 15, 2026
Last update
May 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion